EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers

João Moura iD, Firmina Sambayeta iD, Ana Paula Sousa iD, Paula Carneiro iD, Esmeralda Neves, Raquel Samões iD, Ana Martins Silva, Ernestina Santos

NeuroSci · 17.06.2024 · 5 (2) · 201-208

DOI: 10.3390/neurosci5020015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroSci, online erschienen am 17.06.2024. Verfasst von João Moura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital de Santo António, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugalernestinasantos.neurologia@chpo…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anti-GAD65 antibodies are associated with several neurological phenotypes. Antibody titers are increasingly recognized as useful in diagnosis and prognosis.

Objective

To describe a Portuguese cohort of patients with anti-GAD65-associated neurological syndromes.

Methods

Retrospective analysis of all patients with positive anti-GAD65 antibodies and associated neurological syndromes followed in a tertiary referral center.

Results

Nineteen anti-GAD65 antibody-positive neurological patients were identified, 62.3% female, with a mean age of onset of 56.0 (SD = 13.3) years. Comorbid autoimmune disorders were present in seven patients. Six patients had limbic encephalitis (31.6%), four had epilepsy (21.1%), four had cerebellar ataxia (21.1%), and three had stiff-person syndrome (15.8%). Two patients presented with isolated cognitive dysfunction (executive and mnesic) in the absence of other neurological symptoms. The mean follow-up time was 24.0 (14.0–42.0) months, at the end of which the mean modified Rankin Scale (mRS) value was 2.0 (1.0–4.0). Screening for malignancies was negative in all patients. Serum quantitative analysis was carried out in 18 patients, 10 of whom showed titers above previously defined cut-off points (>10,000 IU/L for ELISA and >20 mmol/L for RIA). Quantitative CSF analysis was performed in nine patients, with four showing above-threshold titers. There was no association between anti-GAD65 levels and clinical phenotype or the final mRS values. High-dose intravenous methylprednisolone and oral prednisolone were the most common acute and chronic treatment regimens, respectively.

Conclusion

Anti-GAD65 antibodies are associated with varied neurological syndromes, and antibody titers alone should not be used to exclude a disease.

Schlagwörter

Stichwörter der Autor:innen

anti-GAD65cerebellar ataxiaepilepsylimbic encephalitisstiff-person syndrome

Autor:innen und Institutionen

  • Department of Neurology, Hospital de Santo António, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugalernestinasantos.neurologia@chporto.min-saude.pt (E.S.).
  • Department of Neurophysiology, Hospital de Santo António, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal.
  • Department of Immunology, Hospital de Santo António, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal.
  • Unit of Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, 4099-001 Porto, Portugal.
  • Laboratory for Integrative and Translational Research in Population Health (ITR), 4099-001 Porto, Portugal.

ORCID-Profile: João Moura, Firmina Sambayeta, Ana Paula Sousa, Paula Carneiro, Raquel Samões

Zitieren

APA

Moura, J., Sambayeta, F., Sousa, A. P., Carneiro, P., Neves, E., Samões, R., Silva, A. M., & Santos, E. (2024). Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers. NeuroSci, 5(2), 201-208. https://doi.org/10.3390/neurosci5020015

Vancouver

Moura J, Sambayeta F, Sousa AP, Carneiro P, Neves E, Samões R, et al. Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers. NeuroSci. 2024;5(2):201-208. doi:10.3390/neurosci5020015

BibTeX
@article{Moura2024,
  author = {Moura, João and Sambayeta, Firmina and Sousa, Ana Paula and Carneiro, Paula and Neves, Esmeralda and Samões, Raquel and Silva, Ana Martins and Santos, Ernestina},
  title = {Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers},
  journal = {NeuroSci},
  year = {2024},
  volume = {5},
  number = {2},
  pages = {201--208},
  doi = {10.3390/neurosci5020015}
}
Kostenlos starten →